Newly published results from a multinational study co-authored by Kenneth Ataga, MD, director of the Center for Sickle Cell Disease at the University of Tennessee Health Science Center (UTHSC) and the Memphis Consortium for Sickle Cell Disease and Non-Malignant Hematology Research, indicated voxelotor, a novel experimental drug for sickle cell disease, reduced anemia and boosted… Read More
Retinal neovascularization (RNV) occurs when new blood vessels grow on the surface of the retina. While wound repair in the skin and many other tissues involves neovascularization, in the eye, neovascularization can cause severe vision loss and blindness. Nikhlesh K. Singh, DVM, PhD, assistant professor in the Department of Physiology in the College of Medicine at… Read More
Memphian and prostate cancer survivor Kenneth Carpenter understands the power of education and conversation. “When I was diagnosed, I knew I needed to educate myself on prostate cancer and start talking about it,” Carpenter said. “I needed to ‘man up to prostate cancer.’ Men, in particular African-American men, are quiet about their health, and are… Read More
Hao Chen, PhD, associate professor in the Department of Pharmacology, and Robert W. Williams, PhD, professor and chair in the Department of Genetics, Genomics and Informatics at the University of Tennessee Health Science Center (UTHSC), have been awarded over $3.14 million in funding to establish an innovative, diverse research model, which will be used to… Read More
Researchers at the University of Tennessee Health Science Center (UTHSC) were part of the federally-funded Women’s Health Initiative (WHI) multisite clinical trial, which released study findings last week showing that postmenopausal women with no previous history of breast cancer reportedly had a 21 percent lower risk of death from breast cancer if they followed a… Read More
Alex Dopico, MD, PhD, University Distinguished Professor and chair of the Department of Pharmacology at the University of Tennessee Health Science Center (UTHSC), has been awarded over $2.4 million from the National Heart, Lung, and Blood Institute (NHLBI) to explore the mechanisms by which our bodies regulate arterial diameter and thus develop new drug therapies… Read More
Colleen Jonsson, PhD, professor and Endowed Van Vleet Chair of Excellence in Virology at the University of Tennessee Health Science Center (UTHSC), has been awarded over $21 million in funding to establish a Center of Excellence for Encephalitic Alphavirus Therapeutics program aimed at advancing the discovery and development of potent antiviral drug candidates targeting several… Read More
The University of Tennessee Health Science Center’s (UTHSC) Junling Wang, PhD, professor in the Department of Clinical Pharmacy and Translational Science, has been awarded over $1.4 million from the National Institutes of Health (NIH) to further her research on the equity and economic effects of medication management therapy programs. Her project titled, “Equity and Economic Effects… Read More
